Back to Search Start Over

Assessing histone demethylase inhibitors in cells : lessons learned

Authors :
Hatch, Stephanie B.
Yapp, Clarence
Montenegro, Raquel Carvalho
Savitsky, Pavel
Gamble, Vicki
Tumber, Anthony
Ruda, Gian Filippo
Bavetsias, Vassilios
Fedorov, Oleg
Atrash, Butrus
Raynaud, Florence
Lanigan, Rachel
Carmichael, LeAnne
Tomlin, Kathy
Burke, Rosemary
Westaway, Susan M.
Brown, Jack A.
Prinjha, Rab K.
Martinez, Elisabeth D.
Oppermann, Udo
Schofield, Christopher J.
Bountra, Chas
Kawamura, Akane
Blagg, Julian
Brennan, Paul E.
Rossanese, Olivia
Müller, Susanne
Hatch, Stephanie B.
Yapp, Clarence
Montenegro, Raquel Carvalho
Savitsky, Pavel
Gamble, Vicki
Tumber, Anthony
Ruda, Gian Filippo
Bavetsias, Vassilios
Fedorov, Oleg
Atrash, Butrus
Raynaud, Florence
Lanigan, Rachel
Carmichael, LeAnne
Tomlin, Kathy
Burke, Rosemary
Westaway, Susan M.
Brown, Jack A.
Prinjha, Rab K.
Martinez, Elisabeth D.
Oppermann, Udo
Schofield, Christopher J.
Bountra, Chas
Kawamura, Akane
Blagg, Julian
Brennan, Paul E.
Rossanese, Olivia
Müller, Susanne
Publication Year :
2017

Abstract

Background: Histone lysine demethylases (KDMs) are of interest as drug targets due to their regulatory roles in chromatin organization and their tight associations with diseases including cancer and mental disorders. The first KDM inhibitors for KDM1 have entered clinical trials, and efforts are ongoing to develop potent, selective and cell-active ‘probe’ molecules for this target class. Robust cellular assays to assess the specific engagement of KDM inhibitors in cells as well as their cellular selectivity are a prerequisite for the development of high-quality inhibitors. Here we describe the use of a high-content cellular immunofluorescence assay as a method for demonstrating target engagement in cells. Results: A panel of assays for the Jumonji C subfamily of KDMs was developed to encompass all major branches of the JmjC phylogenetic tree. These assays compare compound activity against wild-type KDM proteins to a catalytically inactive version of the KDM, in which residues involved in the active-site iron coordination are mutated to inactivate the enzyme activity. These mutants are critical for assessing the specific effect of KDM inhibitors and for revealing indirect effects on histone methylation status. The reported assays make use of ectopically expressed demethylases, and we demonstrate their use to profile several recently identified classes of KDM inhibitors and their structurally matched inactive controls. The generated data correlate well with assay results assessing endogenous KDM inhibition and confirm the selectivity observed in biochemical assays with isolated enzymes. We find that both cellular permeability and competition with 2-oxoglutarate affect the translation of biochemical activity to cellular inhibition. Conclusions: High-content-based immunofluorescence assays have been established for eight KDM members of the 2-oxoglutarate-dependent oxygenases covering all major branches of the JmjC-KDM phylogenetic tree. The usage of both full-length, wi

Details

Database :
OAIster
Notes :
application/octet-stream, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1362793230
Document Type :
Electronic Resource